PMID- 35674941 OWN - NLM STAT- MEDLINE DCOM- 20220610 LR - 20220824 IS - 1940-6029 (Electronic) IS - 1064-3745 (Linking) VI - 2517 DP - 2022 TI - Isolation of Candida auris in Clinical Specimens. PG - 3-20 LID - 10.1007/978-1-0716-2417-3_1 [doi] AB - Candida auris is a multidrug-resistant yeast causing healthcare-associated outbreaks of blood stream infections worldwide. Currently, C. auris isolation and identification is complicated by issues such as misidentification and long turnaround time associated with application of commonly used diagnostic tools. Based on phenotypic characteristics, differentiation of C. auris from related Candida haemulonii complex spp. is problematic. Candida auris can be misidentified using biochemical-based systems such as VITEK 2 YST, API 20C, BD Phoenix yeast identification system, and MicroScan. C. auris growth at 42 degrees C and in the presence of 10% NaCl helps in presumptive identification of this yeast from related Candida haemulonii complex spp. A new CHROMagar Candida Plus agar is an excellent alternative to current conventional mycological media for the screening of patients colonized/infected with Candida auris. Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) can differentiate C. auris from other Candida species, but not all the reference databases included in MALDI-TOF devices allow for detection. Currently, accurate identification of C. auris can be performed using the updated FDA-approved libraries or "research use-only" libraries. Molecular techniques have greatly enhanced the diagnosis of C. auris. Sequencing of rDNA genetic loci, namely, internal transcribed spacer and D1/D2 region of large subunit (LSU), and PCR/qPCR assays has successfully been applied for identification of C. auris. Real-time PCR assays bear incomparable potential of being the most efficient tool for high-throughput screening of surveillance samples. If properly validated, they can deliver the diagnostic result within several hours, since the DNA can be isolated directly from the patient specimen without the need of obtaining a colony. In this chapter we detailed the isolation of Candida auris from various clinical specimens and its currently available identification methods and hitches. CI - (c) 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature. FAU - Yadav, Anamika AU - Yadav A AUID- ORCID: 0000-0002-1735-9904 AD - Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India. AD - Department of Zoology, Ramjas College, University of Delhi, Delhi, India. FAU - Singh, Ashutosh AU - Singh A AUID- ORCID: 0000-0002-6807-7130 AD - Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India. singh90.ashutosh@gmail.com. FAU - Chowdhary, Anuradha AU - Chowdhary A AUID- ORCID: 0000-0002-2028-7462 AD - Medical Mycology Unit, Department of Microbiology, Vallabhbhai Patel Chest Institute, University of Delhi, Delhi, India. LA - eng PT - Journal Article PL - United States TA - Methods Mol Biol JT - Methods in molecular biology (Clifton, N.J.) JID - 9214969 RN - 0 (Antifungal Agents) SB - IM MH - Antifungal Agents MH - Candida/genetics MH - Candida auris MH - *Candidiasis/diagnosis MH - Humans MH - Saccharomyces cerevisiae MH - Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods OTO - NOTNLM OT - CHROMagar Candida OT - Candida auris OT - Misidentification OT - Molecular identification OT - Phenotypic identification EDAT- 2022/06/09 06:00 MHDA- 2022/06/11 06:00 CRDT- 2022/06/08 11:21 PHST- 2022/06/08 11:21 [entrez] PHST- 2022/06/09 06:00 [pubmed] PHST- 2022/06/11 06:00 [medline] AID - 10.1007/978-1-0716-2417-3_1 [doi] PST - ppublish SO - Methods Mol Biol. 2022;2517:3-20. doi: 10.1007/978-1-0716-2417-3_1.